Inalways (5398) - Net Assets

Latest as of March 2026: NT$513.38 Million TWD ≈ $16.17 Million USD

Based on the latest financial reports, Inalways (5398) has net assets worth NT$513.38 Million TWD (≈ $16.17 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$576.89 Million ≈ $18.18 Million USD) and total liabilities (NT$63.51 Million ≈ $2.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 5398 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets NT$513.38 Million
% of Total Assets 88.99%
Annual Growth Rate 6.15%
5-Year Change -5.74%
10-Year Change -12.4%
Growth Volatility 33.17

Inalways - Net Assets Trend (2015–2025)

This chart illustrates how Inalways's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Inalways market capitalisation.

Annual Net Assets for Inalways (2015–2025)

The table below shows the annual net assets of Inalways from 2015 to 2025. Also explore Inalways (5398) net asset momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 NT$530.62 Million
≈ $16.72 Million
-2.85%
2024-12-31 NT$546.17 Million
≈ $17.21 Million
+8.24%
2023-12-31 NT$504.59 Million
≈ $15.90 Million
-6.47%
2022-12-31 NT$539.52 Million
≈ $17.00 Million
-4.16%
2021-12-31 NT$562.96 Million
≈ $17.74 Million
-0.68%
2020-12-31 NT$566.84 Million
≈ $17.86 Million
+1.09%
2019-12-31 NT$560.74 Million
≈ $17.67 Million
+5.70%
2018-12-31 NT$530.49 Million
≈ $16.71 Million
-15.39%
2017-12-31 NT$627.01 Million
≈ $19.75 Million
+3.51%
2016-12-31 NT$605.72 Million
≈ $19.08 Million
+107.28%
2015-12-31 NT$292.23 Million
≈ $9.21 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Inalways's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 656000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components NT$553.20 Million 104.25%
Total Equity NT$530.62 Million 100.00%

Inalways Competitors by Market Cap

The table below lists competitors of Inalways ranked by their market capitalization.

Company Market Cap
Arco Vara AS
F:AV1
$22.13 Million
Blackrock World Mining Trust Plc
LSE:BRWM
$22.15 Million
Gale Pacific Ltd
AU:GAP
$22.15 Million
NOMADAR Corp. Class A Common Stock
NASDAQ:NOMA
$22.16 Million
Atech OEM
TWO:6109
$22.12 Million
BPM Minerals Ltd
AU:BPM
$22.10 Million
Country Club Hospitality & Holidays Limited
NSE:CCHHL
$22.10 Million
African Media Entertainment
JSE:AME
$22.10 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inalways's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 546,169,000 to 530,624,000, a change of -15,545,000 (-2.8%).
  • Net income of 17,357,000 contributed positively to equity growth.
  • Other factors decreased equity by 32,902,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income NT$17.36 Million +3.27%
Other Changes NT$-32.90 Million -6.2%
Total Change NT$- -2.85%

Book Value vs Market Value Analysis

This analysis compares Inalways's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.32x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 1.13x to 1.32x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 NT$12.55 NT$14.20 x
2018-12-31 NT$10.72 NT$14.20 x
2019-12-31 NT$11.34 NT$14.20 x
2020-12-31 NT$11.46 NT$14.20 x
2021-12-31 NT$11.38 NT$14.20 x
2022-12-31 NT$10.91 NT$14.20 x
2023-12-31 NT$10.20 NT$14.20 x
2024-12-31 NT$11.04 NT$14.20 x
2025-12-31 NT$10.73 NT$14.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inalways utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.27%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.55%
  • • Asset Turnover: 0.38x
  • • Equity Multiplier: 1.13x
  • Recent ROE (3.27%) is above the historical average (-3.35%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -37.13% -53.68% 0.59x 1.17x NT$-137.73 Million
2016 1.48% 2.68% 0.43x 1.27x NT$-51.63 Million
2017 2.88% 3.31% 0.70x 1.24x NT$-44.66 Million
2018 -11.71% -11.69% 0.84x 1.19x NT$-115.19 Million
2019 4.52% 5.85% 0.65x 1.19x NT$-30.75 Million
2020 2.94% 4.53% 0.57x 1.14x NT$-40.02 Million
2021 2.88% 4.61% 0.54x 1.15x NT$-40.08 Million
2022 -1.26% -2.64% 0.42x 1.13x NT$-60.74 Million
2023 -6.30% -16.49% 0.35x 1.10x NT$-82.27 Million
2024 1.60% 3.67% 0.37x 1.20x NT$-45.87 Million
2025 3.27% 7.55% 0.38x 1.13x NT$-35.71 Million

Industry Comparison

This section compares Inalways's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $4,834,679,900
  • Average return on equity (ROE) among peers: 7.33%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Inalways (5398) NT$513.38 Million -37.13% 0.12x $22.13 Million
Grape King Bio Ltd (1707) $2.08 Billion 18.27% 0.54x $403.71 Million
Standard Chemical & Pharmaceutical Co Ltd (1720) $8.14 Billion 10.26% 0.37x $314.71 Million
Maywufa Co Ltd (1731) $1.72 Billion 4.41% 0.55x $86.89 Million
ScinoPharm Taiwan Ltd (1789) $10.51 Billion 2.32% 0.11x $452.16 Million
Lotus Pharmaceutical Co Ltd (1795) $7.70 Billion 0.10% 1.03x $1.49 Billion
GeneFerm Biotechnology Co Ltd (1796) $892.84 Million 13.96% 0.32x $38.14 Million
LIWANLI Innovation Co Ltd (3054) $1.02 Billion 0.09% 0.04x $141.28 Million
YungShin Global Holding Corp (3705) $6.16 Billion 14.50% 0.50x $469.95 Million
TTY Biopharm Co Ltd (4105) $8.05 Billion 19.36% 0.41x $615.74 Million
Phytohealth Corp (4108) $2.08 Billion -9.93% 0.06x $70.71 Million

About Inalways

TWO:5398 Taiwan Drug Manufacturers - Specialty & Generic
Market Cap
$22.13 Million
NT$702.41 Million TWD
Market Cap Rank
#24865 Global
#1540 in Taiwan
Share Price
NT$14.20
Change (1 day)
-0.35%
52-Week Range
NT$13.95 - NT$30.65
All Time High
NT$47.05
About

Mediera Corporation manufactures electronic and power supply components in Taiwan. It is also involved in the medical biotechnology business. The company offers medicines, health food, and medical device, etc. Mediera Corporation was founded in 1967 and is based in New Taipei City, Taiwan.